Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CURONASDAQ:NCPLNASDAQ:NRBONASDAQ:PWM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCUROCURO Group$0.04$0.04$0.04▼$2.25$1.69M2.21984,281 shsN/ANCPLNetcapital$2.66+7.7%$2.09$1.41▼$11.90$5.83M-0.13239,377 shs312,951 shsNRBONeuroBo Pharmaceuticals$0.75-0.3%$0.84$2.08▼$5.30$20.33M-0.2651,044 shs53,481 shsPWMPrestige Wealth$0.38-5.8%$0.39$0.31▼$2.70$5.53M3.08629,271 shs90,446 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCUROCURO Group0.00%0.00%0.00%0.00%-25.45%NCPLNetcapital+7.69%-0.75%+30.39%+40.00%-66.81%NRBONeuroBo Pharmaceuticals-3.23%+8.68%+15.38%-49.32%-80.47%PWMPrestige Wealth-5.82%-3.29%-9.07%-27.91%-52.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCUROCURO GroupN/AN/AN/AN/AN/AN/AN/AN/ANCPLNetcapital1.0411 of 5 stars0.05.00.00.02.60.00.6NRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/APWMPrestige Wealth0.9509 of 5 stars0.05.00.00.03.50.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCUROCURO Group 0.00N/AN/AN/ANCPLNetcapital 0.00N/AN/AN/ANRBONeuroBo Pharmaceuticals 0.00N/AN/AN/APWMPrestige Wealth 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCUROCURO Group$418.33M0.00$2.05 per share0.02($1.34) per share-0.03NCPLNetcapital$812.61K7.18N/AN/A$115.96 per share0.02NRBONeuroBo PharmaceuticalsN/AN/AN/AN/A$1.50 per shareN/APWMPrestige Wealth$639.91K8.64N/AN/A$0.34 per share1.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCUROCURO Group-$266.73M-$6.49N/AN/AN/A-35.34%N/A-8.23%N/ANCPLNetcapital-$4.99M-$20.20N/A1.90N/A-562.71%-25.03%-22.67%8/4/2025 (Estimated)NRBONeuroBo Pharmaceuticals-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%8/12/2025 (Estimated)PWMPrestige Wealth-$6.88MN/A0.00∞N/AN/AN/AN/AN/ALatest CURO, NRBO, NCPL, and PWM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/17/2025Q3 2025NCPLNetcapital-$0.70-$1.57-$0.87-$1.57$1.13 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCUROCURO Group$0.441,073.17%N/AN/A N/ANCPLNetcapitalN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/APWMPrestige WealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCUROCURO GroupN/A9.339.33NCPLNetcapitalN/A0.350.35NRBONeuroBo PharmaceuticalsN/A2.412.41PWMPrestige WealthN/A1.121.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCUROCURO Group39.87%NCPLNetcapital30.69%NRBONeuroBo Pharmaceuticals1.37%PWMPrestige Wealth7.68%Insider OwnershipCompanyInsider OwnershipCUROCURO Group26.12%NCPLNetcapital6.77%NRBONeuroBo Pharmaceuticals1.05%PWMPrestige WealthN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCUROCURO Group5,20041.30 million30.51 millionOptionableNCPLNetcapitalN/A2.19 million1.72 millionNot OptionableNRBONeuroBo Pharmaceuticals108.62 million8.53 millionNot OptionablePWMPrestige Wealth414.47 millionN/ANot OptionableCURO, NRBO, NCPL, and PWM HeadlinesRecent News About These CompaniesAnalyzing Prestige Wealth (NASDAQ:PWM) & Core Scientific (NASDAQ:CORZ)June 7, 2025 | americanbankingnews.comPrestige Wealth Inc. Updates Securities Agreement with InvestorsApril 23, 2025 | tipranks.comPrestige Wealth Inc. Announces COO ResignationApril 11, 2025 | tipranks.comPrestige Wealth Inc. Class A Ordinary Shares (PWM) SEC FilingsApril 8, 2025 | nasdaq.comPrestige Wealth receives noncompliance notification from NasdaqApril 3, 2025 | markets.businessinsider.comPrestige Wealth Inc. Amends Share Structure in Recent MeetingsMarch 31, 2025 | tipranks.comPrestige Wealth Inc. to Change Business AddressMarch 27, 2025 | globenewswire.comPrestige Wealth subsidiary InnoSphere recently launched AI financial news agentMarch 21, 2025 | markets.businessinsider.comPrestige Wealth Inc. Schedules Key Meeting on Share StructureMarch 13, 2025 | tipranks.comPrestige Wealth’s InnoSphere integrates DeepSeekMarch 12, 2025 | markets.businessinsider.comPrestige Wealth Inc. Announces Major Upgrade of InnoSphere Tech Inc. with Integration of DeepSeek AI TechnologyMarch 12, 2025 | quiverquant.comPrestige Wealth Inc. announces that its subsidiary InnoSphere integrates DeepSeek, accelerating full-scale transformation into AI FintechMarch 12, 2025 | globenewswire.comPrestige Wealth Inc. Secures $5 Million Through Private PlacementMarch 10, 2025 | tipranks.comIs Prestige Wealth Inc. (PWM) The Best Day Trading Stock To Invest In Now?March 3, 2025 | insidermonkey.comPrestige Wealth Inc. Appoints New CTO Following Board ResignationFebruary 24, 2025 | tipranks.comPrestige Wealth stock hits 52-week low at $0.55 amid market challengesFebruary 14, 2025 | msn.comPrestige Wealth Inc. Reports Financial Results for First Half of Fiscal Year 2024, Highlights Strategic Initiatives and Revenue GrowthFebruary 13, 2025 | quiverquant.comPrestige Wealth Inc. Reports First Half Fiscal 2024 Results with Strategic Growth InitiativesFebruary 13, 2025 | tipranks.comPrestige Wealth Inc. Announces First Half of Fiscal Year 2024 Financial ResultsFebruary 13, 2025 | globenewswire.comPrestige Wealth Inc. Announces Leadership Transition Amidst Strategic ExpansionJanuary 8, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCURO, NRBO, NCPL, and PWM Company DescriptionsCURO Group NYSE:CUROCURO Group Holdings Corp., together with its subsidiaries, provides consumer finance products in the United States and Canada. The company offers secured and unsecured installment loans, revolving line of credit, and single-pay loans; and credit protection insurance, check cashing, money transfer, foreign currency exchange, and other ancillary financial products and services, as well as reloadable prepaid debit cards and demand deposit accounts. The company also provides loans through online. It operates under the Covington Credit, Heights Finance, Quick Credit, Southern Finance, First Heritage Credit, Cash Money, LendDirect, and Flexiti brands. The company was formerly known as Speedy Group Holdings Corp. and changed its name to CURO Group Holdings Corp. in May 2016. CURO Group Holdings Corp. was founded in 1997 and is headquartered in Chicago, Illinois.Netcapital NASDAQ:NCPL$2.66 +0.19 (+7.69%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$2.72 +0.06 (+2.41%) As of 06/13/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Netcapital Inc. operates as a fintech company. It offers Netcapital.com, an SEC-registered funding portal that enables private companies to raise capital online, as well as allows investors to invest from anywhere in the world. The company also provides various services, including automated onboarding process and filing of required regulatory documents; compliance review; custom-built offering page on its portal website; third party transfer agent and custodial services; and rolling closes which provides access to liquidity before final close date of offerings, as well as assistance with annual fillings and direct access to team for ongoing support. In addition, it offers advisor services, which includes incubation of technology start-ups; investors introduction; online marketing; website design and software development; message crafting including pitch decks, offering pages, and ad creation; strategic advice; and technology consulting services. Further, the company provides valuation services, such as business valuation, fairness and solvency opinions, ESOP feasibility and valuation, non-cash charitable contribution, economic analysis of damages, intellectual property appraisals, and compensation studies. Netcapital Inc. is based in Boston, Massachusetts.NeuroBo Pharmaceuticals NASDAQ:NRBO$0.75 0.00 (-0.33%) As of 06/12/2025NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.Prestige Wealth NASDAQ:PWM$0.38 -0.02 (-5.82%) Closing price 06/13/2025 03:35 PM EasternExtended Trading$0.39 +0.01 (+2.09%) As of 06/13/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Wealth Inc., through its subsidiaries, provides wealth management and asset management services. It assists its clients in identifying and purchasing wealth and asset management products. The company offers its services primarily for high net worth and ultra-high net worth individuals, including business owners, executives, heirs of rich families, and other affluent individuals in Asia primarily in the mainland China or Hong Kong. The company was incorporated in 2018 and is based in Central, Hong Kong. Prestige Wealth Inc. is a subsidiary of Prestige Financial Holdings Group Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
